NEW YORK (GenomeWeb News) – Genetic testing information firm NextGxDx announced on Tuesday that is has raised $1 million in a private round of financing.

NextGxDx closed on the angel-funded, convertible note round and met its capital goal with the Series A2 financing, the Nashville, Tenn.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.